ZIMMER BIOMET HLDGS DL-01
ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
ZIM
|
04/10/2024 17:35:53
|
Var.
-0.6800
|
Volume |
Denaro21:59:58 |
Lettera21:59:58 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
95.0800EUR
|
-0.71%
|
20
Fatturato: 1,901.6000 |
95.2200Quantità in denaro: 120 |
95.5000Quantità in lettera: 120 |
19.42 bill.EUR |
- |
- |
Descrizione business
Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Ivan Tornos |
| Consiglio di amministrazione |
| Suketu Upadhyay, Mark Bezjak, Rachel Ellingson, Nitin Goyal, David J. Kunz, Angela Main, Keri P. Mattox, Chad Phipps, Paul Stellato, Zeeshan Tariq, Kenneth R. Tripp, Lori Winkler, Sang Yi, Wilfred van Zuilen |
| Consiglio di sorveglianza |
| Christopher B. Begley, Betsy J. Bernard, Michael J. Farrell, Robert A. Hagemann, Ivan Tornos, Arthur J. Higgins, Maria Teresa Hilado, Syed Jafry, Sreelakshmi Kolli, Michael W. Michelson |
Dati aziendali
| Name: |
Zimmer Biomet Holdings Inc. |
| Indirizzo: |
345 East Main Street,Warsaw, Indiana 46580, USA |
| Telefono: |
+1-574-373-3121 |
| Fax: |
- |
| E-mail: |
surveys@zimmerbiomet.com
|
| Internet: |
www.zimmerbiomet.com/ |
| Industria: |
Healthcare |
| Settore: |
Medical Products |
| Sub settore: |
Advanced Medical Devices |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
74.90% |
| Data dell'IPO: |
03/08/2001 |
Company calendar
|
CW 44 | 31/10/2024
Dividend Payment
|
